Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Conclusion: Consequently, implementing a KD improved CBF and raised BDNF levels in cognitively healthy individuals, indicating its potential as a valuable tool to prevent cognitive decline
There was a significant reduction in LS-mean change from baseline in AUC Glucose0-2h at 12 weeks both in the high GLP-1 and low GLP-1 groups with a greater degree of reduction seen in the high GLP-1 group compared to the low GLP-1 group by -156.26 mmol/L.min (95% CI -272.81, -39.72 mmol/L.min)
The Science Behind GLP-1 Medications GLP-1, or Glucagon-Like Peptide-1 , is a naturally occurring hormone that regulates appetite, glucose levels, and digestion
Kim J, Okamoto H, Huang Z et al (2017) Amino acid transporter Slc38a5 controls glucagon receptor inhibition-induced pancreatic alpha cell hyperplasia in mice
US$ 22.44
US$ 28.56
US$ 22.89
US$ 20.86
US$ 28.87
